Genetic activation of the MST4‐pβ‐cateninThr40 axis exacerbates ISC‐driven colorectal cancer (CRC); and hyperactivation of this axis is clinically correlated with poor prognosis. The gene discussed is STK26; the disease is colorectal carcinoma.